This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (12)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Joe V. Selby, MD, MPH

JAMA. 1993;269(10):1294-1296.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The past year has witnessed substantial gains in our knowledge regarding colorectal cancer screening tests. In this issue of THE JOURNAL, Ahlquist et al¹ provide the best estimate yet of the sensitivity of currently available fecal occult blood tests (FOBTs) for asymptomatic cancer. Confirming what has been suspected previously,^2-4 their data indicate that both Hemoccult and HemoQuant methods detect less than 50% of these cancers. Even if we adjust this estimate upward to account for some loss of sensitivity during mailing, estimated sensitivity would not approach 50%.

The authors describe clearly the errors inherent in the many, usually higher, estimates of sensitivity that have been offered over the years. Simply put, the sensitivity of FOBT for asymptomatic cancer cannot be accurately estimated from studies in persons with symptomatic cancers. Both FOBT and full colonoscopy must be performed in several thousand asymptomatic persons to identify those with cancer in . . . [Full Text PDF of this Article]

Author Affiliations
From the Division of Research, Kaiser Permanente Medical Care Program, Oakland, Calif.

Footnotes
Reprint requests to Division of Research, Kaiser Permanente Medical Care Program, 3451 Piedmont Ave, Oakland, CA 94611 (Dr Selby).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?